Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal Carcinomatosis
CompletedOBSERVATIONAL
Enrollment
166
Participants
Timeline
Start Date
September 30, 2012
Primary Completion Date
July 31, 2023
Study Completion Date
December 31, 2023
Conditions
Peritoneal Carcinomatosis
Trial Locations (1)
51092
Chu Reims, Reims
All Listed Sponsors
lead
CHU de Reims
OTHER
NCT06318793 - Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal Carcinomatosis | Biotech Hunter | Biotech Hunter